Large-Scale Clinical Trial in China Proves AI Decision Support Reduces Secondary Vascular Events by Over 25 Percent

A massive clinical trial in China shows that AI-assisted decision support improves stroke care quality and significantly reduces long-term vascular complications.

By: AXL Media

Published: Mar 23, 2026, 5:40 AM EDT

Source: Information for this report was sourced from BMJ Group

The Integration of Artificial Intelligence in Acute Neurology

A sophisticated clinical decision support system is transforming the landscape of stroke management by bridging the gap between complex diagnostic imaging and immediate treatment action. The tool, evaluated in a rigorous trial across 77 hospitals in China, utilizes artificial intelligence to analyze brain scans while simultaneously providing clinicians with tailored, evidence-based therapy recommendations. This dual approach ensures that the underlying cause of an ischemic stroke is identified with high precision, allowing for a more standardized level of care that mitigates the inconsistencies often found in high-pressure emergency environments.

Quantifying the Reduction in Secondary Vascular Risks

The most compelling evidence from the three-year trial is the measurable impact on patient longevity and health stability. Data from 21,603 patients showed that those treated in hospitals using the AI system experienced significantly fewer follow-up vascular events, including recurrent strokes and heart attacks. At the three-month mark, the intervention group saw a 26% reduction in these life-threatening events compared to the control group. This protective effect was not only maintained but slightly improved by the one-year follow-up, reaching a 27% reduction in secondary complications, proving the system’s value in long-term secondary prevention.

Elevating Performance Measures in Resource-Constrained Settings

The implementation of the AI tool led to a marked increase in overall stroke care quality performance, rising to 91.4% compared to 89.8% in hospitals providing usual care. This improvement is particularly vital in regions with heavy cerebrovascular disease burdens and limited specialized personnel. By automating the classification of stroke causes and taking into account patient variables such as age, medication history, and lifestyle, the system serves as a scalable "force multiplier" for medical staff. This ensures that even in smaller or over-burdened facilities, patients receive a level of care consistent with top-tier academic medical centers.